IP Verse

Preservative Free Bimatoprost And Timolol Solutions - EP2598118B1

PatentPatent Analysis

EP2598118

ALLERGAN
Application Number
EP11745860A
Filing Date
Jul 28, 2011
Status
Revoked
Apr 27, 2024
Grant Date
Sep 5, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2442821B2
EP3509559B8
EP2877138B1

Bibliography

The patent EP2598118B1 was granted to Allergan on Sep 5, 2018 following the initial filing on Jul 28, 2011 under the application number EP11745860A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDJun 5, 2019ADMISSIBLE
ALFRED E TIEFENBACHERJun 4, 2019ADMISSIBLE
BAUSCH HEALTH IRELANDJun 4, 2019ADMISSIBLE
HGFJun 4, 2019WITHDRAWN
WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIGJun 4, 2019WITHDRAWN
STADA ARZNEIMITTELMay 29, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents